# United States 12 Month Oil Fund, LP: financial statements, quarterly

USL · NYSE · CIK 1405528 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/usl.md) · [Financials](/companies/usl/financials.md) · [Filings](/companies/usl/filings.md) · [Insiders](/companies/usl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/usl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [15.7](/filings/0001410578-25-000243.md) | [(9.7)](/filings/0001410578-25-000243.md) | [8.4](/filings/0001104659-26-021509.md) | [1.0](/filings/0001104659-26-021509.md) | [(6.9)](/filings/0001104659-26-021509.md) | [3.1](/filings/0001104659-26-021509.md) | [0.5](/filings/0001104659-26-057771.md) | [(3.9)](/filings/0001104659-26-092628.md) | [0.5](/filings/0001104659-26-021509.md) | [(2.4)](/filings/0001104659-26-021509.md) | [17.0](/filings/0001104659-26-057771.md) | [(1.7)](/filings/0001104659-26-092628.md) |
| Net income | $m | [15.5](/filings/0001410578-25-000243.md) | [(9.8)](/filings/0001410578-25-000243.md) | [8.3](/filings/0001104659-26-021509.md) | [0.9](/filings/0001104659-26-021509.md) | [(7.0)](/filings/0001104659-26-021509.md) | [2.9](/filings/0001104659-26-021509.md) | [0.3](/filings/0001104659-26-057771.md) | [(4.0)](/filings/0001104659-26-092628.md) | [0.4](/filings/0001104659-26-021509.md) | [(2.5)](/filings/0001104659-26-021509.md) | [16.9](/filings/0001104659-26-057771.md) | [(1.9)](/filings/0001104659-26-092628.md) |

- Revenue: us-gaap:Revenues
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [26.4](/filings/0001410578-24-001823.md) | [23.5](/filings/0001104659-26-021509.md) | [38.4](/filings/0001410578-25-001167.md) | [41.0](/filings/0001410578-25-001638.md) | [36.9](/filings/0001104659-25-108398.md) | [31.9](/filings/0001104659-26-021509.md) | [34.1](/filings/0001104659-26-057771.md) | [36.1](/filings/0001104659-26-092628.md) | [35.4](/filings/0001104659-25-108398.md) | [31.8](/filings/0001104659-26-092628.md) | [53.4](/filings/0001104659-26-057771.md) | [34.8](/filings/0001104659-26-092628.md) |
| Total assets | $m | [77.4](/filings/0001410578-23-002214.md) | [67.2](/filings/0001410578-25-000243.md) | [64.1](/filings/0001410578-24-000686.md) | [65.0](/filings/0001410578-24-001231.md) | [54.0](/filings/0001410578-24-001823.md) | [49.6](/filings/0001104659-26-021509.md) | [47.9](/filings/0001410578-25-001167.md) | [42.4](/filings/0001410578-25-001638.md) | [41.0](/filings/0001104659-25-108398.md) | [36.8](/filings/0001104659-26-092628.md) | [65.5](/filings/0001104659-26-057771.md) | [40.7](/filings/0001104659-26-092628.md) |
| Total liabilities | $m | [1.3](/filings/0001410578-23-002214.md) | [0.2](/filings/0001410578-25-000243.md) | [0.1](/filings/0001410578-24-000686.md) | [0.1](/filings/0001410578-24-001231.md) | [0.2](/filings/0001410578-24-001823.md) | [0.2](/filings/0001104659-26-021509.md) | [0.2](/filings/0001410578-25-001167.md) | [0.1](/filings/0001410578-25-001638.md) | [0.2](/filings/0001104659-25-108398.md) | [0.2](/filings/0001104659-26-092628.md) | [5.7](/filings/0001104659-26-057771.md) | [0.1](/filings/0001104659-26-092628.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [3,182 d](/filings/0001410578-24-001823.md) | [(29.0) d](/filings/0001104659-26-021509.md) | [1,056](/filings/0001410578-25-001167.md) | [2,498 d](/filings/0001410578-25-001638.md) | [376 d](/filings/0001104659-25-108398.md) | [(360) d](/filings/0001104659-26-021509.md) | [211](/filings/0001104659-26-057771.md) | [(1,943) d](/filings/0001104659-26-092628.md) | [(438) d](/filings/0001104659-25-108398.md) | [(1,023) d](/filings/0001104659-26-021509.md) | [7,401](/filings/0001104659-26-057771.md) | [5,718 d](/filings/0001104659-26-092628.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

Shares outstanding: 900,000 at 2026-08-04, from the cover of the [10-Q filed 2026-08-07](/filings/0001104659-26-092628.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.